One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Japan Cardiovascular Devices Market

Japan Cardiovascular Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)


Product Code : MDHC00121701
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - IBM Corporation
- Oracle Corporation
- Internap Corporation
- Packet Inc. (An Equinix Inc. Company)
- Scaleway Inc.
- Amazon Web Services Inc
- Rackspace Inc.
- CenturyLink, Inc.
- LightEdge Solutions, Inc

[Report Description]

The Japan Cardiovascular Devices Market is expected to register a CAGR of 2.6% during the forecast period. The major factors driving the growth of the market in Japan is increasing the burden of cardiovascular diseases and increased adoption of minimally invasive procedures.



Japan has the world’s fastest aging population. According to the World Ageing 2019 report, estimates the number of population who are above 65 years of age in Japan was 35.524 million (28%) in 2019 which is projected to reach 37.278 million (30.9%) in 2030. As the number of geriatric population is expected to increase in the coming years who are more prone to chronic diseases such as cardiovascular diseases which ultimately rises the growth of the market in the near future.



Thus, owing to the rising geriatric population along with a high prevalence of heart diseases is expected to show significant growth over the forecast period.



Key Market Trends



Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period



An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart s health.



Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Moreover, there has been an increase in the incidence of cardiovascular diseases (CVD), wherein long-term ECG monitoring is necessary and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further fuels the market growth.



As per the Foundation for Promotion of Cancer Research 2018 report, in 2017, the total number of deaths caused by heart diseases in Japan was about 204.84 thousand cases up from 198.01 thousand cases in 2016 and 196.11 thousand cases in 2015. Thus, owing to the above-mentioned factors along with increasing healthcare expenditure, the segment is expected to show a significant growth rate in the coming years.



Competitive Landscape



The Japan cardiovascular devices market is consolidated competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Medtronic PLC, Cardinal Health Inc., Biotronik, Siemens Healthineers AG, W. L. Gore & Associates, Inc, and Canon Medical Systems Corporation.



Additional Benefits:



  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Cardiovascular Diseases
4.2.2 Increased Preference of Minimally Invasive Procedures
4.3 Market Restraints
4.3.1 Stringent Regulatory Policies
4.3.2 High Cost of Instruments and Procedures
4.4 Porter s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Diagnostic and Monitoring Devices
5.1.1.1 Electrocardiogram (ECG)
5.1.1.2 Remote Cardiac Monitoring
5.1.1.3 Other Diagnostic and Monitoring Devices
5.1.2 Therapeutic and Surgical Devices
5.1.2.1 Cardiac Assist Devices
5.1.2.2 Cardiac Rhythm Management Device
5.1.2.3 Catheter
5.1.2.4 Grafts
5.1.2.5 Heart Valves
5.1.2.6 Stents
5.1.2.7 Other Therapeutic and Surgical Devices

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Boston Scientific Corporation
6.1.3 Cardinal Health Inc
6.1.4 Medtronic PLC
6.1.5 Edwards Lifesciences
6.1.6 Biotronik
6.1.7 Siemens Healthineers AG
6.1.8 Canon Medical Systems Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+